-
What We Fund: $25.2M to Studies toward Restorative Sleep, Better Cognitive Function and More Improvements
April 18, 2023
… from Sanofi that is currently in a Phase III trial for multiple sclerosis. Researchers believe that, given the … Services has rolled out a new electronic data collection system that requires physicians to participate in reporting …
-
Two More Alpha-synuclein Drugs in Clinical Trials
August 14, 2015
… Biogen is testing an antibody (much like those the immune system manufactures to fight viruses and bacteria) designed … but the transition to clinical testing is monumental. Multiple companies in this space increases our likelihood of …
-
Parkinson’s Clinical Trials: Why Clinical Trials Matter for Parkinson’s and the Vital Role Participants Play
July 17, 2026
… about joining a clinical study, including digital guides in multiple languages: … prevent these clumps from spreading so the body’s immune system can clear them. The study will enroll 900 …
-
“New Study Reveals $52-Billion Annual Economic Burden of Parkinson’s” (Spring/Summer 2019)
May 17, 2019
… how patients, care partners, payers, employers, healthcare systems and government programs are all impacted by the …
-
-
FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson’s and Related Diseases
September 9, 2024
… by Parkinson’s published the first biological staging system for Parkinson’s disease known as the neuronal alpha-synuclein disease integrated staging system (NSD-ISS) , in The Lancet Neurology . The staging … Ltd. operates from Dublin, Ireland with additional staff in multiple other locations. For more information, visit us at …